Importantly, Tu-Gr1+CD11b+ invoked a gene expression signature in 4T1 cells that predicted lung metastasis, shorter overall survival (OS), and relapse-free survival (RFS) in breast cancer patients, emphasizing the clinical relevance of these findings. The gene discussed is ITGAM; the disease is breast carcinoma.